Efficacy of 2 years of entecavir plus adefovir therapy in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analog treatment

Antiviral Research

Volumn 103, Issue 1, 2014, Pages 71-77

  Wang, Xiaohong ^a   Zhang, Changjiang ^a   Zhu, Yan ^a   Xiong, Yulin ^a   Wang, Yuming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adefovir dipivoxil; Chronic hepatitis B; Effectiveness; Entecavir; Rescue therapy; Safety

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; NUCLEOSIDE ANALOG; VIRUS DNA; ADEFOVIR DIPIVOXIL; ADENINE; ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; DRUG DERIVATIVE; GUANINE; PHOSPHONIC ACID DERIVATIVE;

ADULT; ALOPECIA; ANTIVIRAL THERAPY; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEADACHE; HEPATITIS B; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOPHOSPHATEMIA; LIVER PAIN; MAJOR CLINICAL STUDY; MALE; ORAL MUCOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROCONVERSION; TREATMENT DURATION; TREATMENT RESPONSE; ADVERSE DRUG REACTION; BLOOD; CHRONIC HEPATITIS B; DRUG COMBINATION; EFFICACY; METHODOLOGY; RESCUE THERAPY; SAFETY; SALVAGE THERAPY; TREATMENT OUTCOME;

ADEFOVIR DIPIVOXIL; CHRONIC HEPATITIS B; EFFECTIVENESS; ENTECAVIR; RESCUE THERAPY; SAFETY;

ADENINE; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; COHORT STUDIES; DNA, VIRAL; DRUG THERAPY, COMBINATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GUANINE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; MALE; ORGANOPHOSPHONATES; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84893707879     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.01.009     Document Type: Article

References (28)

1. M. Bifano, J.H. Yan, R.A. Smith, D. Zhang, D.M. Grasela, and F. LaCreta Absence of a pharmacokinetic interaction between entecavir and adefovir J. Clin. Pharmacol. 47 2007 1327 1334 (Pubitemid 47459664)
2. S. Carrouée-Durantel, D. Durantel, B. Werle-Lapostolle, C. Pichoud, L. Naesens, J. Neyts, C. Trépo, and F. Zoulim Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants Antivir. Ther. 13 2008 381 388 (Pubitemid 352016731)
3. H.B. Chae, M.J. Kim, E.G. Seo, Y.H. Choi, H.S. Lee, J.H. Han, S.M. Yoon, S.M. Park, and S.J. Youn High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B Korean J. Hepatol. 18 2012 75 83
4. T.T. Chang, C.L. Lai, S. Kew Yoon, S.S. Lee, H.S. Coelho, F.J. Carrilho, F. Poordad, W. Halota, Y. Horsmans, N. Tsai, H. Zhang, D.J. Tenney, R. Tamez, and U. Iloeje Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B Hepatology 51 2010 422 430
5. T.T. Chang, Y.F. Liaw, S.S. Wu, E. Schiff, K.H. Han, C.L. Lai, R. Safadi, S.S. Lee, W. Halota, Z. Goodman, Y.C. Chi, H. Zhang, R. Hindes, U. Iloeje, S. Beebe, and B. Kreter Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
6. C.J. Chen, H.I. Yang, J. Su, C.L. Jen, S.L. You, S.N. Lu, G.T. Huang, U.H. Iloeje, and REVEAL-HBV Study Group Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73 (Pubitemid 43042691)
7. J. Chen, J. Yin, X. Tan, H. Zhang, H. Zhang, B. Chen, W. Chang, S. Schaefer, and G. Cao Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2 J. Clin. Virol. 38 2007 238 243 (Pubitemid 46275526)
8. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association The guideline of prevention and treatment for chronic hepatitis B (2010 version) Zhonghua Gan Zang Bing Za Zhi 19 2011 13 21
9. Y. Cho, D.H. Lee, K.H. Chung, E. Jin, J.H. Lee, E.J. Cho, S.J. Yu, J.W. Kim, S.H. Jeong, J.H. Yoon, H.S. Lee, C.Y. Kim, and Y.J. Kim The efficacy of adefovir plus entecavir combination therapy in patients with chronic hepatitis B refractory to both lamivudine and adefovir Dig. Dis. Sci. 58 2013 1363 1370
10. W.E. Delaney IV, H. Yang, M.D. Miller, C.S. Gibbs, and S. Xiong Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro Antimicrob. Agents Chemother. 48 2004 3702 3710 (Pubitemid 39310516)
11. S.K. Fung, and A.S. Lok Management of hepatitis B patients with antiviral resistance Antivir. Ther. 9 2004 1013 1026 (Pubitemid 40040275)
12. D. Ganem, and A.M. Prince Hepatitis B virus infection - natural history and clinical consequences N. Engl. J. Med. 350 2004 1118 1129 (Pubitemid 38298992)
13. J.W. Jeon, H.P. Shin, J.I. Lee, K.R. Joo, J.M. Cha, J.J. Park, J.U. Lim, K. Lim, and S. Kim Efficacy of entecavir and adefovir combination therapy for patients with lamivudine- and entecavir-resistant chronic hepatitis B Dig. Dis. Sci. 57 2012 1358 1365
14. S.S. Kim, J.Y. Cheong, D. Lee, M.H. Lee, S.P. Hong, S.O. Kim, and S.W. Cho Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B J. Med. Virol. 84 2012 18 25
15. N.W. Leung, C.L. Lai, T.T. Chang, R. Guan, C.M. Lee, K.Y. Ng, S.G. Lim, P.C. Wu, J.C. Dent, S. Edmundson, L.D. Condreay, R.N. Chien, and Asia Hepatitis Lamivudine Study Group Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy Hepatology 33 2001 1527 1532 (Pubitemid 32496991)
16. Y.F. Liaw Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy Antivir. Ther. 11 2006 669 679
17. Y.F. Liaw, J.J. Sung, W.C. Chow, G. Farrell, C.Z. Lee, H. Yuen, T. Tanwandee, Q.M. Tao, K. Shue, O.N. Keene, J.S. Dixon, D.F. Gray, J. Sabbat, and Cirrhosis Asian Lamivudine Multicentre Study Group Lamivudine for patients with chronic hepatitis B and advanced liver disease N. Engl. J. Med. 351 2004 1521 1531
18. Y.F. Liaw, E. Gane, N. Leung, S. Zeuzem, Y. Wang, C.L. Lai, E.J. Heathcote, M. Manns, N. Bzowej, J. Niu, S.H. Han, S.G. Hwang, Y. Cakaloglu, M.J. Tong, G. Papatheodoridis, Y. Chen, N.A. Brown, E. Albanis, K. Galil, N.V. Naoumov, and GLOBE Study Group 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B Gastroenterology 136 2009 486 495
19. Y.S. Lim, J.Y. Lee, D. Lee, J.H. Shim, H.C. Lee, Y.S. Lee, and D.J. Suh Randomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovir Antimicrob. Agents Chemother. 56 2012 2941 2947
20. F.M. Lu, and H. Zhuang Management of hepatitis B in China Chin. Med. J. (Engl.) 122 2009 3 4
21. P. Marcellin, T.T. Chang, S.G. Lim, W. Sievert, M. Tong, S. Arterburn, K. Borroto-Esoda, D. Frederick, and F. Rousseau Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B Hepatology 48 2008 750 758
22. G.V. Papatheodoridis, E. Dimou, K. Dimakopoulos, S. Manolakopoulos, I. Rapti, G. Kitis, D. Tzourmakliotis, E. Manesis, and S.J. Hadziyannis Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine Hepatology 42 2005 121 129 (Pubitemid 40911319)
23. S.Y. Seo, I.H. Kim, J.Y. Sohn, S. Lee, and S.H. Kim Long-term efficacy of entecavir plus adefovir combination therapy versus entecavir monotherapy in adefovir refractory chronic hepatitis B patients with prior lamivudine resistance Intervirology 57 2014 8 16
24. S. Villet, C. Pichoud, G. Billioud, L. Barraud, S. Durantel, C. Trépo, and F. Zoulim Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure J. Hepatol. 48 2008 747 755
25. X.H. Xu, G.L. Li, Y. Qin, Q. Li, and F.Q. He Entecavir plus adefovir rescue therapy for chronic hepatitis B patients after multiple treatment failures in real-life practice Virol. J. 10 2013 162 166
26. H.J. Yang, J.H. Lee, Y.J. Kim, J.H. Yoon, and H.S. Lee Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine- resistant hepatitis B virus with or without adefovir resistance J. Med. Virol. 84 2012 424 430
27. H.J. Yim, M. Hussain, Y. Liu, S.N. Wong, S.K. Fung, and A.S. Lok Evolution of multi-drug resistant hepatitis B virus during sequential therapy Hepatology 44 2006 703 712 (Pubitemid 44433727)
28. F. Zoulim, and S. Locarnini Management of treatment failure in chronic hepatitis B J. Hepatol. 56 Suppl. 1 2012 S112 S122